These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10657866)

  • 1. Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
    Petrilli AS; Dantas LS; Campos MC; Tanaka C; Ginani VC; Seber A
    Med Pediatr Oncol; 2000 Feb; 34(2):87-91. PubMed ID: 10657866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
    Minotti V; Gentile G; Bucaneve G; Iori AP; Micozzi A; Cavicchi F; Barbabietola G; Landonio G; Menichetti F; Martino P; Del Favero A
    Support Care Cancer; 1999 May; 7(3):134-9. PubMed ID: 10335931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone in the outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Kullmann KH; Ritter J; Jürgens H
    Eur J Clin Microbiol Infect Dis; 1998 Jul; 17(7):501-4. PubMed ID: 9764553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
    Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C; Dussart S; Fuhrmann C; Ghesquieres H; Rodrigues I; Geoffrois L; Devaux Y; Lancry L; Chvetzoff G; Bachelot T; Chelghoum M; Biron P
    Support Care Cancer; 2008 Sep; 16(9):1017-23. PubMed ID: 18197434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A; Marchigiani D; Walsh T; Chanock S; Lewis L; Hiemenz J; Hiemenz S; Hicks JE; Gill V; Steinberg SM; Pizzo PA
    N Engl J Med; 1999 Jul; 341(5):305-11. PubMed ID: 10423464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftriaxone monotherapy in the treatment of low-risk febrile neutropenia.
    Karthaus M; Wolf HH; Kämpfe D; Egerer G; Ritter J; Peters G; Südhoff T; Franke A; Heil G; Kullmann KH; Jürgens H
    Chemotherapy; 1998; 44(5):343-54. PubMed ID: 9732151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E; Bodmer N; Simon A; Leibundgut K; Kühne T; Niggli FK; Ammann RA
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outpatient treatment of cancer patients with fever and neutropenia.
    Karthaus M; Egerer G; Jürgens H
    Antibiot Chemother (1971); 2000; 50():47-58. PubMed ID: 10874454
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A; Swaroop C; Agarwala S; Pandey RM; Bakhshi S
    J Pediatr Hematol Oncol; 2009 Sep; 31(9):635-41. PubMed ID: 19684522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
    Zubizarreta P; Paganini H
    Med Pediatr Oncol; 2002 Apr; 38(4):292. PubMed ID: 11920803
    [No Abstract]   [Full Text] [Related]  

  • 15. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM; Herrera L; Sandler ES; Buchanan GR
    Cancer; 2000 Apr; 88(7):1710-4. PubMed ID: 10738231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
    Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children.
    Charnas R; Lüthi AR; Ruch W
    Pediatr Infect Dis J; 1997 Apr; 16(4):346-53. PubMed ID: 9109134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient antimicrobial protocol for febrile neutropenia: a nonrandomized prospective trial using ceftriaxone, amikacin, and oral adjuvant agents.
    Sahu S; Bapna A; Pai SK; Nair CN; Kurkure PA; Advani SH
    Pediatr Hematol Oncol; 1997; 14(3):205-11. PubMed ID: 9185205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
    Petrilli A; Altruda Carlesse F; Alberto Pires Pereira C
    Pediatr Blood Cancer; 2007 Oct; 49(5):682-6. PubMed ID: 17253640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.